Screener
Kestra Medical Technologies KMTS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Kestra Medical Technologies’s 10-Q, filed September 14, 2026. Open the filing →
- Filed
- Sep 14, 2026, 5:15 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001193125-26-390766
FAQ
- What is Kestra Medical Technologies's EPS (diluted)?
- Kestra Medical Technologies (KMTS) reported EPS (diluted) of -$0.75 in Q2 2026.
- How has Kestra Medical Technologies's EPS (diluted) changed year-over-year?
- Kestra Medical Technologies's EPS (diluted) decreased by 50.0% year-over-year, from -$0.50 to -$0.75.
- What is the long-term trend for Kestra Medical Technologies's EPS (diluted)?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's EPS (diluted) has grown at a -30.9% compound annual growth rate (CAGR), from -$5.07 to -$2.42.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Kestra Medical Technologies's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude